| Most Popular Article Of The Week:


OOVA Launches Perimenopause Hormone Kit

Oova Kit offers Estrogen Biomarker and App with Real-Time Data Tracking

Oova, a leading women’s health platform offering remote hormone monitoring, has launched the at-home Perimenopause Hormone Kit that monitors hormone changes during perimenopause to track and confirm ovulation. The kit comes complete with urine-based, multi-hormone biomarkers including estrogen (E3G) and an app with real-time data tracking. Unlike other options on the market, which rely on blood or FSH-only urine tests that only capture a moment in time, Oova users are able to measure their actual hormone fluctuations across a 15-day period throughout a single cycle and their progress month-over-month. This gives women and their physicians insights into their perimenopause journey.  

The test strips are scanned into Oova’s HIPPA-compliant app, which utilizes advanced AI and machine learning to interpret the scan into quantitative results that can be understood by patients and clinicians alike. By interpreting the quantitative levels over time, Oova’s predictive algorithms begin to learn the nuances of every woman’s unique hormone profile to help her achieve her health goal. Insights include measuring perimenopausal hormone activity; tracking unique physical symptoms, indicating fertility; and confirming ovulation for those trying to conceive during perimenopause. It also enables monitoring of hormone patterns for those beginning Hormone Replacement Therapy (HRT). Patients can also share their data with clinicians in real-time, from the comfort of home.

“There are significant gaps in hormone health research, especially as it relates to perimenopause,” said Amy Divaraniya, Ph.D., founder and CEO of OOVA. “We know doctors and patients alike are missing methods to pinpoint where someone is in their journey and identify how symptoms correspond to hormone changes, which often leaves women navigating this life phase in the dark. With the Perimenopause Hormone Kit, women can better understand their bodies, while tracking data that empowers them to make informed decisions with their physicians.” 

“Oova’s test serves as a significant leap forward in healthcare,” said Beck Hoehn, advisor to Oova. “In this stage of women’s health that has traditionally been passed over, Oova’s perimenopause kit equips both the patient and clinician with real-time, accurate insight needed to navigate the complexities with confidence and clarity. It’s a game-changer.”

The launch of the E3G biomarker expands upon Oova’s current physician-preferred fertility monitoring offering of luteinizing hormone (LH) and progesterone (PdG) biomarkers to complete the Perimenopause Hormone Kit. The Perimenopause Hormone Kit ($159.99), retailing online and in store at Village Pharmacy, includes 15 E3G tests and 15 LH/PdG hormone tests, designed to be used over the course of a month for a detailed and comprehensive picture of hormone behavior. Also available is The Oova Perimenopause Membership Kit ($129.99/month) for an ongoing test strip subscription with full-circle support from Oova’s hormone specialists and access to the Oova community.

About The Author

Julie is the co-founder of Well Defined and a longtime influencer and advocate in the wellness world. Along with her work at Well Defined, she is an executive recruiter and marketing specialist for Hutchinson Consulting. She is also a consultant and content strategist for numerous wellness brands. She is the former editor-in-chief and publisher of American Spa and was named a 2019 Folio Top Woman in Media in the Industry Trailblazers category and a 2018 winner of ISPA’s Innovate Award. She is also a seasoned journalist, specializing in spa, travel, health, fitness, wellness, sustainability, and beauty. She has been published in Departures,, E! Online,, Insider’s Guide to Spas, Luxury Travel Advisor, Marin Magazine, Ocean Home, Smart Meetings, Spa Asia, and Travel Agent.